Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells
…, DJ Vander Griend, L Antony… - Proceedings of the …, 2006 - National Acad Sciences
Androgen receptor (AR) protein expression and function are critical for survival and
proliferation of androgen-sensitive (AS) prostate cancer cells. Besides its ability to function as a …
proliferation of androgen-sensitive (AS) prostate cancer cells. Besides its ability to function as a …
Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells
IV Litvinov, DJ Vander Griend, Y Xu, L Antony… - Cancer research, 2006 - AACR
Stage-specific differentiation markers were used to evaluate the cellular composition and
the origin of nonimmortalized (PrEC) and immortalized (PZ-HPV7, CA-HPV10, RWPE-1, and …
the origin of nonimmortalized (PrEC) and immortalized (PZ-HPV7, CA-HPV10, RWPE-1, and …
Conformational diversity in prion protein variants influences intermolecular β‐sheet formation
A conformational transition of normal cellular prion protein (PrP C ) to its pathogenic form (PrP
Sc ) is believed to be a central event in the transmission of the devastating neurological …
Sc ) is believed to be a central event in the transmission of the devastating neurological …
Tasquinimod is an allosteric modulator of HDAC4 survival signaling within the compromised cancer microenvironment
JT Isaacs, L Antony, SL Dalrymple, WN Brennen… - Cancer research, 2013 - AACR
Tasquinimod is an orally active antiangiogenic drug that is currently in phase III clinical trials
for the treatment of castration-resistant prostate cancer. However, the target of this drug has …
for the treatment of castration-resistant prostate cancer. However, the target of this drug has …
Adaptive auto‐regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer
JT Isaacs, JM D'Antonio, S Chen, L Antony… - The …, 2012 - Wiley Online Library
Cell culture/xenograft and gene arrays of clinical material document that development of
castration resistant prostate cancer (CRPC) cells involves acquisition of adaptive auto‐…
castration resistant prostate cancer (CRPC) cells involves acquisition of adaptive auto‐…
Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β‐catenin/TCF‐4 complex inhibition of c‐MYC transcription
L Antony, F Van Der Schoor, SL Dalrymple… - The …, 2014 - Wiley Online Library
INTRODUCTION Physiologic testosterone continuously stimulates prostate stromal cell
secretion of paracrine growth factors (PGFs), which if unopposed would induce hyperplastic …
secretion of paracrine growth factors (PGFs), which if unopposed would induce hyperplastic …
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor
IV Litvinov, L Antony, SL Dalrymple, R Becker… - The …, 2006 - Wiley Online Library
BACKGROUND Androgen receptor (AR) functions in normal prostate epithelium as a tumor
suppressor to inhibit continuous proliferation of these cells. Such tumor suppressor function …
suppressor to inhibit continuous proliferation of these cells. Such tumor suppressor function …
[HTML][HTML] Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
…, Y Zhu, IM Coleman, SL Dalrymple, L Antony… - JCI insight, 2021 - ncbi.nlm.nih.gov
Resistance to AR signaling inhibitors (ARSis) in a subset of metastatic castration-resistant
prostate cancers (mCRPCs) occurs with the emergence of AR–neuroendocrine prostate …
prostate cancers (mCRPCs) occurs with the emergence of AR–neuroendocrine prostate …
[HTML][HTML] Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
…, DM Rosen, SL Dalrymple, L Antony… - The Journal of …, 2022 - Am Soc Clin Investig
Testosterone is the canonical growth factor of prostate cancer but can paradoxically suppress
its growth when present at supraphysiological levels. We have previously demonstrated …
its growth when present at supraphysiological levels. We have previously demonstrated …
Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells
S Dalrymple, L Antony, Y Xu, AR Uzgare, JT Arnold… - Cancer Research, 2005 - AACR
A panel of expression markers was validated and used to document that, when radical
prostatectomy specimens are cultured in low (ie, <260 μmol/L)–calcium (Ca 2+ )-serum-free, …
prostatectomy specimens are cultured in low (ie, <260 μmol/L)–calcium (Ca 2+ )-serum-free, …
